Events

Upcoming Events
Mar 6 - Mar 7, 2024

The 5th Biologics World Nordics 2024 event will bring together biologic and biosimilar developers and manufacturers, technology providers, CMOs and CROs from the Nordics region and beyond to explore partnership and technical collaboration opportunities, discuss best R&D and biomanufacturing practises, and debate growth strategies as Nordics developed biologics enter critical clinical phase II and III development stages.

 

Click here to learn more about the conference

 

Copenhagen, Denmark
Past Events
Jan 11, 2024
If you are a holder of an ADR (American depositary receipt – a US issued certificate representing shares in a foreign company for trade on the American stock exchange) and wish to know what applies in terms of voting or giving proxy, please refer to your depositary agreement with your broker. Notice of general meetings will be published on the company website. If you are a Danish holder of shares you can also sign up for future notices at https://virk.dk/
Dec 9 - Dec 12, 2023

The 65th ASH Annual Meeting and Exposition will take place December 9-12, 2023, in San Diego, California, and online. Mark your calendars now to attend the world’s most comprehensive hematology event of the year, and look forward to Evaxion's presentation.

 

Click here to learn more about the conference

San Diego, United States
Nov 22 - Nov 24, 2023

The 6th Biologics World Nordics 2023 event will bring together biologic and biosimilar developers and manufacturers, technology providers, CMOs and CROs from the Nordics region and beyond to explore partnership and technical collaboration opportunities, discuss best R&D and biomanufacturing practises, and debate growth strategies as Nordics developed biologics enter critical clinical phase II and III development stages.

 

Click here to learn more about the conference.

 

Copenhagen, Denmark
Nov 9 - Nov 11, 2023

NextGen Omics 2023 features 4 outstanding programmes, bringing together Europe’s most successful omics research experts under one roof. The series provides an excellent networking platform which consists of key discussion topics in: Next Generation Sequencing & Clinical Diagnostics, Single Cell & Spatial Analysis, Synthetic Biology in Discovery & Therapeutics and Digital PCR & Liquid Biopsies

 

Click here to learn more about the conference.

 

London, United Kingdom
Nov 8, 2023 from 5:30 PM to 6:00 PM CET
In this presentation, Professor Adnan Khattak will set the scene by introducing participants to the medical field of malignant melanoma and the need that Evaxion’s personalized cancer vaccines is trying to meet.
  • Welcome by Evaxion's Chief Scientific Officer, Birgitte Rønø
  • Lay-man introduction to malignant melanoma, Prof. Adnan Khattak
  • EVX-01 phase 1 results summary, Prof. Adnan Khattak
  • EVX-01 phase 2 initial results, Prof. Adnan Khattak
  • The potential of EVX-01 and PCVs in the treatment of cancer, Prof. Adnan Khattak
  • Q&A
Nov 6 - Nov 8, 2023

From 6th to 8th November 2023 leading biotech and biopharma companies and development teams will gather in Messe Munich to realise BIO-Europe 2023. The show floor will feature an elaborate curated product offering alongside immersive conference agenda. BIO-Europe 2023 will shed light on vital industry topics, including AI, pharmaceuticals, preventative medicine, big data and more.

 

Click here to learn more about the conference.

 

Münich, Germany
Oct 20 - Oct 24, 2023

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2023 will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

 

Click here to learn more about the conference.

 

Madrid, Spain
Oct 10 - Oct 12, 2023

The mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting. This is the first and only forum dedicated to showcasing mRNA cancer vaccine technology advances, translational insights and critical clinical updates from the global leaders working towards effective harnessing of neoantigens and developing successful tailor-made mRNA cancer vaccines. Unite with mRNA cancer vaccine, oncology and immune-oncology leaders and stay up to date about these innovative cancer therapies. With individualized neoantigen therapies showing critical promise in the clinic, neoantigen leaders unite to exhibit a whole-day dedicated to neoantigen discovery and identification, towards optimized discovery and development of personalized cancer vaccines to differentiate and fast track your pipelines.

 

Click here to learn more about the conference.

 

Boston, United States
Sep 24 - Sep 29, 2023

The 23rd International Pathogenic Neisseria Conference aims to bring together passionate scientists, emerging and experienced researchers and clinicians from all continents to discuss the clinical presentation, epidemiology, population genomics, vaccine research and development, host-pathogen interactions and gene regulation of these Neisseria species in order to keep abreast of the latest developments in this field. IPNC is a great opportunity for networking and forming collaborations for future work on pathogenic Neisseria species.

 

Click here to learn more about the conference.

 

Boston, United States
Sep 14 - Sep 15, 2023

Join vaccines leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the vaccines discovery, therapeutics & manufacturing.

 

Click here to learn more about the conference.

 

Berlin, Germany
Jun 5 - Jun 8, 2023
Boston, United States
May 25, 2023 12:30 PM CEST

The R&D Day will feature a series of talks from Evaxion scientists and collaborators, sharing previously unreleased preclinical data highlighting the use of Evaxion’s proprietary genetic immune adjuvant (Antigen Presenting Cell targeting) technology. This technology has been shown to enhance vaccination effects for both DNA and mRNA vaccines across a range of therapeutic vaccine applications.

 

The event will be hosted with the possibility of physical attendance at Evaxion’s facilities in Hørsholm, Denmark and as a live webcast. 

Please write to info@evaxion-biotech.com with the following details to sign up for the physical attendance for R&D day:

 

Subject: R&D Day

Message: Your full name

 

Hørsholm, Denmark

Dr Neergaards Vej 5F,
2970Hørsholm
Denmark

May 24, 2023

If you are a holder of an ADR (American depositary receipt – a US issued certificate representing shares in a foreign company for trade on American stock exchange) and wish to know what applies in terms of voting or giving proxy, please refer to your depositary agreement with your broker.

Notice of general meetings will be published on the company web-site. If you are a Danish holder of shares you can also sign up for future notices at https://virk.dk/

May 3 - May 4, 2023
London, United Kingdom
Apr 3 - Apr 6, 2023

Evaxion will be presenting a scientific presentation on our antigen presenting cell targeting technology for this year's World Vaccine Congress.

 

Reach out to Neil Anderson, VP and Global Head of Business Development (nja@evaxion-biotech.com)

 

Washington, United States
Mar 20 - Mar 23, 2023

Evaxion will be presenting on-site at BIO Europe in Basel this year.

 

If you would like to connect with us, contact Neil Anderson, VP and Global Head of Business Development (nja@evaxion-biotech.com)

 

Basel, Switzerland
Apr 12, 2022
Please join us on Tuesday, April 12th at 12:30 PM EDT for a webinar featuring Key Opinion Leaders Jeffrey S. Weber MD, PhD (NYU-Grossman School of Medicine) and Patrick Ott, MD, PhD (Dana Farber Cancer Institute). Dr. Weber will discuss the current treatment landscape and unmet medical needs in patients with metastatic melanoma. Dr. Ott will discuss the novel neoepitope-targeting approach to improving the treatment for patients suffering from metastatic melanoma. A live Q&A session will follow the discussion.

Subscribe to Investor Email Alerts

Be the first to know about news, milestones and events at Evaxion by subscribing to our investor email alerts.